Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: SARTORIUS AG: Sartorius completes acquisition of Polyplus: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: SARTORIUS AG: Sartorius completes acquisition of Polyplus
EQS-News: SARTORIUS AG: Sartorius completes acquisition of Polyplus
Best Dividend Stocks to Buy: Ford vs. AT&T: https://g.foolcdn.com/editorial/images/740027/untitled-design-10.png
Best Dividend Stocks to Buy: Ford vs. AT&T

Fool.com contributor Parkev Tatevosian compares Ford (NYSE: F) with AT&T (NYSE: T) to determine the better dividend stock to buy right now.

*Stock prices used were the afternoon prices of July 14

Why AT&T Stock Was Sliding Today: https://g.foolcdn.com/editorial/images/740091/5g-cellular-communications-tower.jpg
Why AT&T Stock Was Sliding Today

Shares of AT&T (NYSE: T) were falling today after Citigroup downgraded the telecom stock ahead of its earnings report next week.

The stock was down 4.3% as of 11:26 a.m. ET on Monday.

Citi analyst

Should You Buy the Dip With Biogen Stock Right Now?: https://g.foolcdn.com/editorial/images/739687/investor-ponders-a-screen.jpg
Should You Buy the Dip With Biogen Stock Right Now?

With shares of Biogen (NASDAQ: BIIB) falling by 11% in the last 30 days, and by 20% in the last five years, could there be an opportunity for enterprising investors to buy the dip on this struggling

3 Top Tech Stocks to Buy for the Long Haul: https://g.foolcdn.com/editorial/images/739573/gettyimages-897684502.jpg
3 Top Tech Stocks to Buy for the Long Haul

When many investors think of tech stocks, they think of high growth potential, particularly in a short amount of time. While that can happen, you don't want to invest with only that thought in mind

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
2 Monster Stocks to Buy Without Any Hesitation: https://g.foolcdn.com/editorial/images/739950/gettyimages-1134003590.jpg
2 Monster Stocks to Buy Without Any Hesitation

Everyone's portfolio should include a couple of monster stocks. What do I mean by "monster"? I'm talking about companies that have a solid earnings track record and offer bright prospects down the

These 2 Numbers Should Scare Every Biogen Shareholder: https://g.foolcdn.com/editorial/images/739662/3-worried-investors-talk-at-a-table.jpg
These 2 Numbers Should Scare Every Biogen Shareholder

Most Biogen (NASDAQ: BIIB) shareholders are probably excited about the company's newly approved Alzheimer's drug Leqembi right about now, and it's no surprise why. Some commentators are calling for

3 Dividend Growth Stocks to Buy and Hold: https://g.foolcdn.com/editorial/images/739724/dividend-income.jpg
3 Dividend Growth Stocks to Buy and Hold

Wayne Gretzky probably had no idea how much one thing he said would be repeated through the years. But one of his most famous statements certainly was memorable and worthy of repetition: "I skate to

7 Spectacular High-Yield Dividend Stocks to Buy in July: https://g.foolcdn.com/editorial/images/738988/dividends-blackboard-sketch-doodle.jpg
7 Spectacular High-Yield Dividend Stocks to Buy in July

You don't have to settle for puny dividend income. Thousands of stocks offer dividends. Many of them, though, have dividend yields that don't amount to a hill of beans.

What if you could invest in

Better High-Yield Dividend Stock: Altria or Viatris?: https://g.foolcdn.com/editorial/images/739969/dividends.jpg
Better High-Yield Dividend Stock: Altria or Viatris?

If you are looking for a high-yield dividend stock to boost your income, you might be interested in Altria (NYSE: MO) or Viatris (NASDAQ: VTRS). Both companies offer attractive dividend yields of

The Wild Card That Could Drag Down AT&T Stock: https://g.foolcdn.com/editorial/images/739885/gettyimages-1397206849.jpg
The Wild Card That Could Drag Down AT&T Stock

Shares of telecom giant AT&T (NYSE: T) are historically inexpensive. Based on the company's guidance for 2023, the stock trades at a measly 7 times free cash flow. The dividend yield is also on the

Why Shares of Fresenius Medical Jumped This Week: https://g.foolcdn.com/editorial/images/739861/doctors-white-coat-healthcare-1.jpg
Why Shares of Fresenius Medical Jumped This Week

Shares of Fresenius Medical Care (NYSE: FMS) were up more than 11% for the week as of Friday at 1:30 p.m. ET, according to data provided by S&P Global Market Intelligence. The German healthcare

UnitedHealth Group (UNH) Q2 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
UnitedHealth Group (UNH) Q2 2023 Earnings Call Transcript

Image source: The Motley Fool.

UnitedHealth Group (NYSE: UNH)Q2 2023 Earnings CallJul 14, 2023, 8:45 a.m. ET

Operator

Continue reading

Source Fool.com

Why Shares of UnitedHealth Group Are Up Friday: https://g.foolcdn.com/editorial/images/739809/physicians-in-a-hospital-operating-room.jpg
Why Shares of UnitedHealth Group Are Up Friday

Shares of UnitedHealth Group (NYSE: UNH), the nation's largest private medical insurer, were up more than 6.6% as of 11 a.m. ET on Friday after the company reported second-quarter earnings. The heal

Why AT&T Stock Fell on Friday: https://g.foolcdn.com/editorial/images/739791/1-glowing-red-arrow-trending-down-on-a-stock-chart.jpg
Why AT&T Stock Fell on Friday

Shares of telecom giant AT&T (NYSE: T) fell 3.6% as of 9:50 a.m. ET Friday morning.

You can blame J.P. Morgan for that.

This morning, investment bank J.P. Morgan downgraded AT&T stock from

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed
3 Reasons to Buy Viatris Stock, and 1 Reason to Sell: https://g.foolcdn.com/editorial/images/739304/team-of-medical-experts-talking-on-a-meeting-at-doctors-office.jpg
3 Reasons to Buy Viatris Stock, and 1 Reason to Sell

Buying shares of a generic drug manufacturer like Viatris (NASDAQ: VTRS) isn't the right move for everyone. While most investors would look for such companies to have a long history of bulletproof

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
2 Biotech Stocks That Could Make You Richer: https://g.foolcdn.com/editorial/images/739466/radiologist-of-oncology-institute-is-examing-mri-scans.jpg
2 Biotech Stocks That Could Make You Richer

When looking for stocks that can make one richer, investors often start with names they know. The problem is that the names they know also tend to be the names that everyone knows, and these stocks

Vertex Pharmaceuticals: Buy at the High?: https://g.foolcdn.com/editorial/images/739608/gettyimages-scientist_computer_others-in-background.jpg
Vertex Pharmaceuticals: Buy at the High?

Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed nearly 20% so far this year. And that leaves the stock trading a few dollars off its record high. It's not surprising Vertex has advanced. The

Why Novavax Stock Tumbled 28% in the First Half of 2023: https://g.foolcdn.com/editorial/images/739693/arrow-graph-going-down-stocks-display.jpg
Why Novavax Stock Tumbled 28% in the First Half of 2023

Shares of Novavax (NASDAQ: NVAX) lost 28% of their value in the first six months of the year, according to data from S&P Global Market Intelligence, extending a downtrend that began in early 2022

Why Shares of GoodRx Holdings Climbed This Week: https://g.foolcdn.com/editorial/images/739696/pharmacists-looking-at-pills-in-bottle.jpg
Why Shares of GoodRx Holdings Climbed This Week

Share of GoodRx Holdings (NASDAQ: GDRX) rose more than 32% for the week, as of Thursday at 2:15 p.m. ET, according to data provided by S&P Global Market Intelligence. The healthcare stock is up more

Is Amgen's Dividend Safe?: https://g.foolcdn.com/editorial/images/739641/piggybank.jpg
Is Amgen's Dividend Safe?

Amgen (NASDAQ: AMGN) is a global leader in biotechnology, with a market capitalization of over $121 billion. The company has a proven track record of developing breakthrough therapies for

2 Top Healthcare Stocks to Buy Right Now: https://g.foolcdn.com/editorial/images/739215/healthcare-professionals-talking-to-each-other.jpg
2 Top Healthcare Stocks to Buy Right Now

When you invest in industries that are positioned to capitalize on secular trends, owning wonderful businesses for the long haul is all it takes to build wealth and passive income. As the world's